Synonyms: NE_MS_BL_TreatImm_Siponimod IM_OtherImmun_Siponimod MS_Siponimod
This is just here as a test because I lose it
Term information
hasDefinition
Siponimod, also known as Mayzent, by Novartis, is a new drug formulated for the management of Multiple Sclerosis (MS). It was approved by the FDA on March 26, 2019 6 and by Health Canada on February 20, 2020. This drug is considered a sphingosine-1-phosphate (S1P) receptor modulator and is thought to play a role in suppressing the central nervous system inflammation that is associated with MS